Skip to main content

IDENTIFICACION DEL RIESGO DE CANCER EN PACIENTES CON APNEA OBSTRUCTIVA DEL SUEÑO CON LA DETECCION DE IMMUNOCHECKPOINTS.

PI19/01363

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INVESTIGACION BIOMEDICA HOSPITAL LA PAZ
Execution centre INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO LA PAZ (IdiPAZ)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Obesity attenuates the effect of sleep apnea on active TGF-ß1 levels and tumor aggressiveness in patients with melanoma

  • Cubillos-Zapata, Carolina
  • Martínez García, Miguel Ángel|||0000-0002-7321-1891
  • Díaz-García, Elena
  • Jaureguizar, Ana
  • Campos-Rodríguez, Francisco
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
  • Nagore, Eduardo|||0000-0003-3433-8707
  • Martorell-Calatayud, Antonio
  • Hernández Blasco, Luis Manuel
  • Pastor, Esther
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Montserrat, Josep María
  • Cabriada-Nuño, Valentín|||0000-0003-1124-7108
  • Cano Pumarega, Irene|||0000-0003-1543-7187
  • Corral-Peñafiel, Jaime
  • Arias, Eva
  • Mediano, Olga|||0000-0001-7824-1523
  • Somoza-González, María
  • Dalmau-Arias, Joan
  • Almendros, Isaac|||0000-0002-1998-9379
  • Farré, Ramon|||0000-0002-9084-7824
  • López-Collazo, Eduardo
  • Gozal, David|||0000-0001-8195-6036
  • García Rio, Francisco|||0000-0002-7227-2238
Active transforming growth factor-β1 (TGF-β1), a cytokine partially regulated by hypoxia and obesity, has been related with poor prognosis in several tumors. We determine whether obstructive sleep apnea (OSA) increases serum levels of active TGF-β1 in patients with cutaneous melanoma (CM), assess their relationship with melanoma aggressiveness and analyze the factors related to TGF-β1 levels in obese and non-obese OSA patients. In a multicenter observational study, 290 patients with CM were underwent sleep studies. TGF-β1 was increased in moderate-severe OSA patients vs. non-OSA or mild OSA patients with CM. In OSA patients, TGF-β1 levels correlated with mitotic index, Breslow index and melanoma growth rate, and were increased in presence of ulceration or higher Clark levels. In CM patients, OSA was associated with higher TGF-β1 levels and greater melanoma aggressiveness only in non-obese subjects. An in vitro model showed that IH-induced increases of TGF-β1 expression in melanoma cells is attenuated in the presence of high leptin levels. In conclusion, TGF-β1 levels are associated with melanoma aggressiveness in CM patients and increased in moderate-severe OSA. Moreover, in non-obese patients with OSA, TGF-β1 levels correlate with OSA severity and leptin levels, whereas only associate with leptin levels in obese OSA patients.